The reinforcing and subjective effects of morphine in post-addicts

A dose-response study

R. J. Lamb, K. L. Preston, C. W. Schindler, R. A. Meisch, F. Davis, J. L. Katz, J. E. Henningfield, S. R. Goldberg

Research output: Contribution to journalArticle

Abstract

The reinforcing and subjective effects of morphine were determined in five human volunteers with histories of i.v. heroin abuse. Subjects responded under a second-order schedule of i.m. injection. Under this schedule, every 100 lever presses produced a brief stimulus light [fixed ratio (FR) 100:s]; the 30th completion of the FR 100 requirement turned on the light for 15 min and the subject received an i.m. injection of morphine [FR 30 (FR 100:s)]. Once each weekday morphine or placebo was available under this schedule. Each drug dose was available for 1 week. Under these conditions placebo did not maintain responding; 3.75 mg of morphine maintained responding in four of five subjects, and higher morphine doses (7.5, 15 and 30 mg) maintained responding in all five subjects. Subjective effects were measured concurrently: these included measures of drug liking, the Morphine Benzedrine Group scale of the Addiction Research Center Inventory, drug detection and identification. Subjects did not report subjective effects different from placebo for the lowest dose of morphine; the intermediate doses of morphine produced inconsistent effects, and the highest dose of morphine occasioned reports of drug liking and ''dope'' identifications. These results indicate that there can be a significant dissociation of the reinforcing and the subjective effects of opioids, which has implications for theories of opioid abuse, particuarly those assuming that the reinforcing effects are causally related to the euphoric effects of opioids. Furthermore, these results confirm that measures of reinforcing effects and measures of subjective effects do not necessarily lead to identical predictions when used to assess the liability for abuse of a substance.

Original languageEnglish (US)
Pages (from-to)1165-1173
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume259
Issue number3
StatePublished - 1991

Fingerprint

Morphine
Opioid Analgesics
Appointments and Schedules
Pharmaceutical Preparations
Placebos
Heroin Dependence
Light
Placebo Effect
Injections
Substance-Related Disorders
Volunteers
Equipment and Supplies
Research

ASJC Scopus subject areas

  • Pharmacology

Cite this

Lamb, R. J., Preston, K. L., Schindler, C. W., Meisch, R. A., Davis, F., Katz, J. L., ... Goldberg, S. R. (1991). The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. Journal of Pharmacology and Experimental Therapeutics, 259(3), 1165-1173.

The reinforcing and subjective effects of morphine in post-addicts : A dose-response study. / Lamb, R. J.; Preston, K. L.; Schindler, C. W.; Meisch, R. A.; Davis, F.; Katz, J. L.; Henningfield, J. E.; Goldberg, S. R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 259, No. 3, 1991, p. 1165-1173.

Research output: Contribution to journalArticle

Lamb, RJ, Preston, KL, Schindler, CW, Meisch, RA, Davis, F, Katz, JL, Henningfield, JE & Goldberg, SR 1991, 'The reinforcing and subjective effects of morphine in post-addicts: A dose-response study', Journal of Pharmacology and Experimental Therapeutics, vol. 259, no. 3, pp. 1165-1173.
Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL et al. The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. Journal of Pharmacology and Experimental Therapeutics. 1991;259(3):1165-1173.
Lamb, R. J. ; Preston, K. L. ; Schindler, C. W. ; Meisch, R. A. ; Davis, F. ; Katz, J. L. ; Henningfield, J. E. ; Goldberg, S. R. / The reinforcing and subjective effects of morphine in post-addicts : A dose-response study. In: Journal of Pharmacology and Experimental Therapeutics. 1991 ; Vol. 259, No. 3. pp. 1165-1173.
@article{a9832ec3ba0346ec847c686dc9635d02,
title = "The reinforcing and subjective effects of morphine in post-addicts: A dose-response study",
abstract = "The reinforcing and subjective effects of morphine were determined in five human volunteers with histories of i.v. heroin abuse. Subjects responded under a second-order schedule of i.m. injection. Under this schedule, every 100 lever presses produced a brief stimulus light [fixed ratio (FR) 100:s]; the 30th completion of the FR 100 requirement turned on the light for 15 min and the subject received an i.m. injection of morphine [FR 30 (FR 100:s)]. Once each weekday morphine or placebo was available under this schedule. Each drug dose was available for 1 week. Under these conditions placebo did not maintain responding; 3.75 mg of morphine maintained responding in four of five subjects, and higher morphine doses (7.5, 15 and 30 mg) maintained responding in all five subjects. Subjective effects were measured concurrently: these included measures of drug liking, the Morphine Benzedrine Group scale of the Addiction Research Center Inventory, drug detection and identification. Subjects did not report subjective effects different from placebo for the lowest dose of morphine; the intermediate doses of morphine produced inconsistent effects, and the highest dose of morphine occasioned reports of drug liking and ''dope'' identifications. These results indicate that there can be a significant dissociation of the reinforcing and the subjective effects of opioids, which has implications for theories of opioid abuse, particuarly those assuming that the reinforcing effects are causally related to the euphoric effects of opioids. Furthermore, these results confirm that measures of reinforcing effects and measures of subjective effects do not necessarily lead to identical predictions when used to assess the liability for abuse of a substance.",
author = "Lamb, {R. J.} and Preston, {K. L.} and Schindler, {C. W.} and Meisch, {R. A.} and F. Davis and Katz, {J. L.} and Henningfield, {J. E.} and Goldberg, {S. R.}",
year = "1991",
language = "English (US)",
volume = "259",
pages = "1165--1173",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - The reinforcing and subjective effects of morphine in post-addicts

T2 - A dose-response study

AU - Lamb, R. J.

AU - Preston, K. L.

AU - Schindler, C. W.

AU - Meisch, R. A.

AU - Davis, F.

AU - Katz, J. L.

AU - Henningfield, J. E.

AU - Goldberg, S. R.

PY - 1991

Y1 - 1991

N2 - The reinforcing and subjective effects of morphine were determined in five human volunteers with histories of i.v. heroin abuse. Subjects responded under a second-order schedule of i.m. injection. Under this schedule, every 100 lever presses produced a brief stimulus light [fixed ratio (FR) 100:s]; the 30th completion of the FR 100 requirement turned on the light for 15 min and the subject received an i.m. injection of morphine [FR 30 (FR 100:s)]. Once each weekday morphine or placebo was available under this schedule. Each drug dose was available for 1 week. Under these conditions placebo did not maintain responding; 3.75 mg of morphine maintained responding in four of five subjects, and higher morphine doses (7.5, 15 and 30 mg) maintained responding in all five subjects. Subjective effects were measured concurrently: these included measures of drug liking, the Morphine Benzedrine Group scale of the Addiction Research Center Inventory, drug detection and identification. Subjects did not report subjective effects different from placebo for the lowest dose of morphine; the intermediate doses of morphine produced inconsistent effects, and the highest dose of morphine occasioned reports of drug liking and ''dope'' identifications. These results indicate that there can be a significant dissociation of the reinforcing and the subjective effects of opioids, which has implications for theories of opioid abuse, particuarly those assuming that the reinforcing effects are causally related to the euphoric effects of opioids. Furthermore, these results confirm that measures of reinforcing effects and measures of subjective effects do not necessarily lead to identical predictions when used to assess the liability for abuse of a substance.

AB - The reinforcing and subjective effects of morphine were determined in five human volunteers with histories of i.v. heroin abuse. Subjects responded under a second-order schedule of i.m. injection. Under this schedule, every 100 lever presses produced a brief stimulus light [fixed ratio (FR) 100:s]; the 30th completion of the FR 100 requirement turned on the light for 15 min and the subject received an i.m. injection of morphine [FR 30 (FR 100:s)]. Once each weekday morphine or placebo was available under this schedule. Each drug dose was available for 1 week. Under these conditions placebo did not maintain responding; 3.75 mg of morphine maintained responding in four of five subjects, and higher morphine doses (7.5, 15 and 30 mg) maintained responding in all five subjects. Subjective effects were measured concurrently: these included measures of drug liking, the Morphine Benzedrine Group scale of the Addiction Research Center Inventory, drug detection and identification. Subjects did not report subjective effects different from placebo for the lowest dose of morphine; the intermediate doses of morphine produced inconsistent effects, and the highest dose of morphine occasioned reports of drug liking and ''dope'' identifications. These results indicate that there can be a significant dissociation of the reinforcing and the subjective effects of opioids, which has implications for theories of opioid abuse, particuarly those assuming that the reinforcing effects are causally related to the euphoric effects of opioids. Furthermore, these results confirm that measures of reinforcing effects and measures of subjective effects do not necessarily lead to identical predictions when used to assess the liability for abuse of a substance.

UR - http://www.scopus.com/inward/record.url?scp=0026334513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026334513&partnerID=8YFLogxK

M3 - Article

VL - 259

SP - 1165

EP - 1173

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -